Rasvmaksahaigus

Rasvmaksahaigus, also known as "rasvamaksahaigus" or "rasvamaksahaiguse" in Estonian, is a medical condition characterized by the accumulation of fat in the liver, leading to inflammation and damage. It is a form of non-alcoholic fatty liver disease (NAFLD), which occurs in individuals who do not consume excessive alcohol. The condition is more prevalent in overweight and obese individuals, particularly those with a diet high in saturated fats and sugars.

The exact cause of rasvmaksahaigus is not fully understood, but it is believed to be a result of a combination of genetic and environmental factors. These factors include insulin resistance, metabolic syndrome, and a high-fat diet. The condition can progress from simple fatty liver (steatosis) to non-alcoholic steatohepatitis (NASH), which involves liver inflammation and cell damage. In severe cases, it can lead to cirrhosis and liver failure.

Diagnosis of rasvmaksahaigus typically involves a combination of medical history, physical examination, and imaging tests such as ultrasound or MRI. Blood tests can also be used to assess liver function and detect markers of inflammation. Treatment options depend on the severity of the condition and may include lifestyle modifications such as a healthy diet and regular exercise, as well as medications to manage underlying conditions like diabetes or high cholesterol.

Prevention of rasvmaksahaigus involves maintaining a healthy weight, consuming a balanced diet low in saturated fats and sugars, and engaging in regular physical activity. Regular medical check-ups can also help in early detection and management of the condition.